GRALV Stock - GRAIL, Inc. Common Stock
Unlock GoAI Insights for GRALV
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
GRAIL, LLC, a biotechnology company, focuses on developing technologies for early cancer detection. The company develops Galleri, a screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer. It is also developing minimal residual disease and other post-diagnostic tests. GRAIL, LLC was formerly known as PSC15, Inc. and changed its name to GRAIL, LLC in January 2016. The company was incorporated in 2015 and is based in Menlo Park, California. GRAIL, LLC operates as a subsidiary of Illumina, Inc.
Visit WebsiteEarnings History & Surprises
GRALVLatest News
Frequently Asked Questions about GRALV
What is GRALV's current stock price?
What is the analyst price target for GRALV?
What sector is GRAIL, Inc. Common Stock in?
What is GRALV's market cap?
Does GRALV pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to GRALV for comparison